Carmil

Quick links to important sections

Carmil

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Carmil

Understanding Carmil

Carmil is a pharmacological treatment developed for the management of specific gastrointestinal conditions. It belongs to a class of medications designed to modulate the movement and function of the digestive system, primarily by interacting with specialized receptors in the gut wall.

Therapeutic Purpose

The primary function of Carmil is to assist in the relief of chronic symptoms associated with bowel irregularities where other conservative measures, such as dietary changes or fiber supplementation, have proven insufficient. It is typically utilized in clinical settings to address conditions characterized by infrequent bowel movements or significant abdominal discomfort related to digestive transit time.

Mechanism of Action

Carmil works by mimicking the effects of naturally occurring neurotransmitters that stimulate the muscles in the intestinal tract. By binding to specific serotonin (5-HT4) receptors, the medication helps to:

  • Increase the frequency of muscular contractions in the colon.
  • Improve the speed at which contents pass through the digestive system.
  • Support the restoration of a more regular rhythm to the digestive process.

This mechanism is localized primarily within the gastrointestinal tract, aiming to improve functional motility without significantly affecting other systems of the body.

Clinical Context

As a targeted therapy, Carmil is generally considered when a patient’s quality of life is impacted by persistent digestive challenges. It is intended for long-term management under professional supervision rather than as a temporary solution for acute symptoms. Its use is determined by an assessment of the patient's specific symptoms and their response to previous therapeutic interventions.

Regulatory References

  1. Isosorbide Mononitrate | StatPearls

What side effects are possible with Carmil?

Possible Side Effects and Safety Information

The official safety profile for Carmil (Isosorbide Mononitrate) outlines adverse reactions based on their frequency and grouping them by System-Organ Class, consistent with regulatory standards.

Frequency Classification Example Adverse Reactions (SOC)
Very Common (ge1/10) Headache (Nervous System)
Common (ge1/100 to <1/10) Dizziness, Hypotension, Tachycardia, Fatigue (Vascular, Cardiac, General)
Uncommon (ge1/1,000 to <1/100) Vomiting, Diarrhoea, Flushing (Gastrointestinal, Vascular)

These safety classifications establish that effects related to vasodilation, such as headache and hypotension (low blood pressure), are the most frequently documented adverse reactions, particularly at the start of treatment. Regulatory documents note that initial headaches often diminish within one to two weeks with continued exposure.

Serious adverse reactions documented in official labeling include Severe Hypotension that may lead to syncope or circulatory collapse, and the potential for the Aggravation of Angina Pectoris.

Specific safety restrictions also apply. The medicine is contraindicated for concurrent use with Phosphodiesterase Type-5 (PDE5) inhibitors and soluble Guanylate Cyclase (sGC) stimulators due to the risk of life-threatening severe hypotension. Furthermore, safety considerations exist for special populations, including patients with Hypertrophic Cardiomyopathy, where nitrate therapy may aggravate angina, and in pediatric use, where safety and effectiveness have not been established.

Overdose and Emergency Response

Overdose and When to Seek Help

The overdose profile for Carmil (Isosorbide Mononitrate) is officially documented by regulatory agencies and is primarily defined by exaggerated vasodilatory effects. Suspected overdose requires immediate attention as stipulated by official prescribing information.

Documented Overdose Manifestations

Symptoms officially documented in regulatory labels typically include a severe throbbing headache, hypotension (low blood pressure), vertigo, palpitations, nausea, and vomiting. More severe manifestations, signaling systemic and central nervous system compromise, can involve confusion, syncope (fainting, especially when standing), dyspnea (trouble breathing), heart block, and circulatory failure.

Required Emergency Actions

Regulatory guidance emphasizes that the following actions must be taken in case of an overdose:

  • Seek immediate emergency medical attention upon suspicion of overdose.
  • Contact emergency services if the individual has collapsed, had a seizure, or cannot be awakened.

Overdose Management and Antidote

The official management strategy is supportive, directed toward increasing central fluid volume to counteract hypotension. The regulatory documents state that no specific antagonist is known for the drug’s vasodilatory effects. However, for the rare complication of Methaemoglobinaemia, the documented treatment of choice is Methylene Blue.

Therapeutic Uses of Carmil

What Carmil Treats: Main Uses and Benefits

Carmil (Isosorbide Mononitrate) is commonly used as part of the long-term, prophylactic management of symptoms related to the cardiovascular system. Isosorbide Mononitrate is commonly used for the prevention of angina pectoris associated with coronary artery disease. This medication is applied in a prophylactic context and is not intended for the acute relief of an ongoing anginal episode. It supports patients by addressing the core symptomatic patterns of chronic heart conditions.


Therapeutic Scope

This medicine is relevant for easing symptoms that are linked to functional stability becoming affected. Carmil is typically used to help with the symptomatic management of Chronic Stable Angina Pectoris, a condition that involves recurrent symptoms like chest pain, pressure, and tightness. It is applied to support the management of these frequent manifestations that may be triggered by physical exertion. This approach supports patients during episodes of discomfort, contributing to improved comfort during periods of heightened symptoms.


Quick Fact: Supportive Management for Recurrent Chest Discomfort

Symptom Domain Therapeutic Context Patient Support
Recurrent symptoms like chest pain and pressure Long-term anti-anginal therapy Contributes to improved comfort during symptomatic periods
Effort-induced discomfort Prophylactic management of physiological strain Assists with maintaining functional stability for daily activities

Regulatory References

  1. DailyMed (NIH) overview of Isosorbide Mononitrate

Eligibility and Restrictions for Use

Carmil is a medication that contains Isosorbide Mononitrate, a type of nitrate used to prevent and manage chronic angina pectoris (chest pain related to the heart). Like all prescription medications, it is suitable for certain individuals and contraindicated for others.

Who Can Use Carmil?

Carmil is generally used by adults who have been diagnosed with chronic stable angina to reduce the frequency and severity of angina attacks. It is not intended for the rapid relief of an acute angina attack; for such episodes, a sublingual (under the tongue) nitrate is typically required.

Who Cannot Use Carmil?

Carmil is contraindicated and must not be used by patients with:

  • Hypersensitivity or allergy to isosorbide mononitrate or any related nitrates.
  • Acute circulatory failure (e.g., shock or vascular collapse) or severe hypotension (very low blood pressure).
  • Acute myocardial infarction (heart attack) with low cardiac filling pressures.
  • Certain heart conditions, including constrictive pericarditis, cardiac tamponade, or aortic/mitral stenosis.
  • Concomitant use with Phosphodiesterase Type 5 Inhibitors (e.g., sildenafil) or soluble guanylate cyclase stimulators (e.g., riociguat), as this can lead to a severe and dangerous drop in blood pressure.

Patients with conditions like severe anemia, glaucoma, hypothyroidism, or liver or kidney impairment may require careful monitoring and potential dose adjustments. Pregnant or breastfeeding women should only use this medication if specifically directed and monitored by a healthcare provider.

What should I know about interactions with other medicines?

Carmil Interactions with other medicines and products

The official regulatory profile for Carmil (Isosorbide Mononitrate) outlines critical interactions defined primarily by pharmacodynamic risk and specific co-administration restrictions.

Interaction Classification Interacting Substances (Examples) Regulatory Constraint
Contraindicated Combinations Phosphodiesterase type-5 (PDE5) inhibitors (e.g., Sildenafil, Tadalafil, Vardenafil); Riociguat Use is strictly prohibited due to risk of severe, life-threatening hypotension.
Pharmacodynamic Potentiation Other vasodilators, Antihypertensives, Diuretics, Alcohol Co-administration may result in additive effects that potentiate the hypotensive effect.
Exposure Alteration Dihydroergotamine May increase the blood levels of Dihydroergotamine and potentiate its associated hypertensive effects.

The core structure of the interaction information establishes an absolute prohibition against concurrent use with PDE5 inhibitors and Riociguat based on the potential for severe additive vasodilation. This is the highest level of restriction. Beyond these contraindicated combinations, the regulatory documents note that combining Carmil with alcohol or any agent that lowers blood pressure may lead to potentiated hypotensive effects. Carmil's absorption is not significantly affected by food, meaning it may be taken independent of meals. No population-specific adjustments to interaction severity are explicitly documented.

Mechanism of Action

Molecular Bioactivation and NO / cGMP Signaling

The mechanism of Carmil (Isosorbide Mononitrate) begins with its function as a Nitric Oxide (NO) donor requiring bioactivation within vascular cells. The released NO selectively activates the enzyme Soluble Guanylyl Cyclase (sGC), initiating a signaling cascade that increases the secondary messenger cyclic GMP (cGMP). This molecular sequence directs the subsequent steps, leading to smooth muscle relaxation.


Regulation of Vascular Tone and Preload

The elevated cGMP levels trigger a chain reaction that ultimately leads to the dephosphorylation of the contractile proteins within the vessel wall, causing vascular smooth muscle relaxation. This effect is most pronounced in the peripheral veins, leading to an increase in their capacity and subsequent venous pooling. This physiological adjustment directly reduces the volume of blood returning to the heart, a core hemodynamic parameter known as cardiac preload.


️ Functional Reduction of Cardiac Workload

By lowering the preload, the mechanism modulates the operational requirements of the heart. The reduced blood volume decreases the tension within the ventricular walls, correlating to a reduction in the oxygen required by the myocardium. This adjustment of the cardiac workload represents the final physiological consequence of the drug’s vasodilatory action.

Dosage and Administration Information

How to Use Carmil (Isosorbide Mononitrate)

The usage of Carmil is defined by established procedural protocols centered on a precise daily schedule and specific ingestion rules for the medicine's long-term, prophylactic application. The sole approved route of administration for Carmil is oral. This medication is not intended for the acute relief of an ongoing anginal episode.


Official Dosing and Administration Schedules

Formulation Typical Frequency Labeled Dosage Examples
Immediate Release (IR) Twice Daily Starting at 20 mg two times per day
Extended Release (ER) Once Daily Starting at 30 mg or 60 mg once a day

These dosage schedules are asymmetrical, intentionally structured to include a nitrate-low period daily, which is essential to prevent the development of pharmacological tolerance. The maximum approved daily dose is typically 120 mg across both formulations.


Administration Requirements

Extended-release tablets must be swallowed whole with a drink of water and must not be chewed, crushed, or split. The medication can be taken with or without food.

For older adults, while routine adjustment is not required, starting at the low end of the dosing range may be a consideration. When treatment is concluded, the medicine should not be stopped suddenly; the dosage and frequency must be tapered gradually. If a dose is missed, it should be skipped if it is almost time for the next dose, and the dose must not be doubled.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Carmil (Isosorbide Mononitrate)


Evidence Base for Chronic Stable Angina Pectoris

The evidence for use in Chronic Stable Angina Pectoris relies primarily on findings from Randomized Controlled Trials (RCTs) and systematic reviews. The research primarily was studied for its use in exploring how symptoms change over time related to episodes of chest discomfort. Studies examined outcomes related to functional capacity—for instance, measuring the duration participants could perform on a treadmill before the onset of symptoms—and tracked the patient-reported frequency of anginal episodes per week or month.

Findings from systematic reviews describe patterns observed in the studies where measurements of the duration of exercise before symptom onset were generally longer than those measured in the placebo groups in the short-to-medium term. Research highlights changes measured during the study period, including patterns related to the frequency of reported anginal episodes when the medicine was observed in participants taking it according to a specific schedule. Research describes the medicine's use in a prophylactic setting; the slow onset of action means trials indicate it is not intended for the relief of an acute anginal attack.


The Role of Follow-up and Study Duration

The research exploring Carmil's effects focused mainly on research exploring short-term symptom changes and functional outcomes. These primary trials often monitored patient responses and functional capacity over intervals ranging from a few hours up to approximately 3 to 6 weeks of regular use. These follow-up durations were relevant in trials assessing short-term or episodic symptom patterns.

A key finding that emerged from studies observing chronic administration is the physiological effect known as nitrate tolerance, where the body's response may be diminished over time. Studies that monitored the medicine's activity often incorporated an intentional nitrate-free period (typically 10 to 14 hours each day) to evaluate the effect on physiological activity. This research provides context for understanding symptom patterns but does not determine whether an individual will respond similarly outside of these specific, controlled study conditions.


Key Research Gaps and Uncertainties

While the research provides context for managing symptoms, several important questions remain where the evidence is limited or certainty remains low.

The research largely examines how Carmil was studied for outcomes related to symptoms and functional measures (like exercise time). Dedicated trials have not fully established or focused on the long-term impact on major clinical events, such as all-cause mortality (survival) or the prevention of heart attacks (Myocardial Infarction). Evidence for these hard outcomes is often inferred rather than being the direct focus of the medicine's primary efficacy trials.

Additionally, follow-up durations were limited in many primary studies, meaning that the data for sustained benefits or risks over many years are less defined than the data for short-term effects. This means that subgroup findings are uncertain regarding the long-term patterns of response.

Frequently Asked Questions (FAQ)

Common questions about Carmil (FAQ)


Q: Is Carmil available over the counter?

According to official product information, Carmil, which contains Isosorbide Mononitrate, is classified as a human prescription drug. This means it is not available over the counter and requires a valid prescription from a licensed healthcare provider.


Q: How long does it typically take for Carmil to start working?

Official labeling indicates that Carmil has a slow onset of action. It is designed for the prevention of heart-related chest pain (angina) and its effects are not rapid enough to be used to stop an anginal episode that is already occurring. For immediate relief of an acute episode, a rapidly-acting nitrate is typically required.


Q: Is Carmil considered a long-term or short-term medication?

Carmil is indicated for the prevention of chronic stable angina pectoris. Its official role is that of a long-term, prophylactic medication. This means it is typically prescribed to be taken regularly as an aid in the management and prevention of anginal episodes.


Q: Does Carmil interact with common pain relievers like Ibuprofen or Acetaminophen?

Official documentation notes that common over-the-counter pain relievers, such as Acetaminophen, are often used to relieve headaches caused by this medication. Regulatory documents state that these common pain relievers are generally not expected to interfere with Carmil’s overall efficacy.


Q: What happens if I miss a dose of Carmil?

The official labeling advises patients that if a dose is missed, they must not double the dose to make up for the one that was skipped. They should instead continue with their next scheduled dose.


Q: Does Carmil have a potential for dependence?

Regulatory precautions note that in industrial workers exposed to high doses of nitrates long-term, true physical dependence has been demonstrated upon withdrawal. Official documentation states that the relevance of physical dependence observed in these high-dose industrial settings is unknown in the context of routine clinical use of the prescribed drug.


Q: Is it normal to have a slight headache when first starting Carmil?

Yes, headaches are listed as a very common side effect and are considered by doctors to be a marker of the drug's activity in some patients. Official information notes that these headaches often lessen or disappear after the first one or two weeks of continued treatment.


Q: Is Carmil a common choice for chronic versus acute conditions?

Official documentation confirms that Carmil is indicated for the prevention of chronic stable angina. Because of its slower onset of action, it is not used to treat acute, sudden episodes of chest pain.


Q: Does Carmil have a generic version available?

Yes, the active ingredient in Carmil, Isosorbide Mononitrate, is available from several different manufacturers in generic tablet form. These generic versions contain the same active ingredient as the brand-name Carmil.


Q: Can Carmil affect the results of lab tests or blood work?

Official labeling advises that nitrates, including the active ingredient in Carmil, may interfere with a specific laboratory method used for measuring cholesterol levels. Official labeling warns that this may lead to falsely low readings in a specific method used for serum cholesterol determinations.


Q: Can Carmil cause drowsiness or affect my ability to drive?

The medication is associated with common side effects like dizziness and light-headedness, particularly when rising. Patients experiencing these effects should be aware of the potential impact on activities requiring alertness, such as driving or operating heavy machinery.


Q: Are there specific age limits for who can take Carmil?

The official product information specifically notes that the safety and effectiveness of Isosorbide Mononitrate have not been established in pediatric patients (children).


Q: Why do some people say they feel fatigue while on Carmil?

Fatigue is officially listed as an adverse reaction reported during clinical trials. While the specific cause or physiological mechanism of this effect is not usually detailed in the drug label, the effect is documented as a common experience.


Q: Are there any long-term effects associated with taking Carmil for many years?

Official documentation states that the primary efficacy data comes from controlled trials with limited follow-up periods. Information on the sustained effects, benefits, or risks of use over many years is therefore not defined by these core regulatory studies.


Q: How soon after stopping Carmil will the medication be fully out of my system?

Based on its pharmacokinetic profile, the active ingredient in Carmil has an elimination half-life of approximately 5 hours. This means that most of the dose is expected to be excreted from the body, primarily through the urine, within about 48 hours after the last dose.


Q: Why do doctors recommend taking Carmil for [Condition X] but not [Condition Y]?

Official warnings state that Carmil is indicated for angina prevention, but its use is not recommended for conditions like acute myocardial infarction or congestive heart failure, primarily because its effects are difficult to terminate rapidly if the clinical situation changes.


Q: What does the pill or tablet look like?

Official product information, often accompanied by images, provides a physical description of the tablet. The description specifies characteristics such as the size, shape, color, and imprints found on the pill, such as being film-coated or scored.


Q: Does Carmil affect sleep?

While insomnia is not always listed as a common side effect, the documented adverse reactions such as headache and dizziness may contribute to sleep disturbance in some individuals.


Q: Can Carmil be cut or crushed?

For the extended-release (ER) tablet formulation, regulatory guidelines explicitly state that these tablets must be swallowed whole. They must not be chewed, crushed, or split because doing so would alter the drug's intended slow-release mechanism.


Q: What kind of pain is Carmil best for treating?

The official indication for Carmil is the prevention of angina pectoris. This specific type of pain is chest pain that occurs due to insufficient blood flow to the heart muscle. It is not generally indicated for the management of other types of non-cardiac pain.


Q: Why would someone need to stop taking Carmil?

Reasons to stop using the medication include experiencing severe hypotension (very low blood pressure), a severe allergic reaction, or being diagnosed with a medical condition that is specifically listed as a contraindication for its use.


Q: What is the purpose of the coating on the Carmil tablet?

The coating on a Carmil tablet is typically made of inactive ingredients. For extended-release tablets, the coating and overall structure are essential elements designed to ensure the active ingredient is released slowly and consistently over an extended period.


Q: What are the risks of taking Carmil while breastfeeding?

Official regulatory documents state that it is not known whether this drug is excreted in human breast milk. Due to this uncertainty, official regulatory documents advise that caution is required when considering administration to a nursing mother.


Q: What is the scientific research supporting the use of Carmil?

Official regulatory documents summarize the evidence by noting that the antianginal activity of the drug has been demonstrated in controlled clinical trials. These studies found that the drug significantly increased exercise tolerance time compared to a placebo.


How should Carmil be stored and disposed of?

How to Store and Dispose of Carmil (Isosorbide Mononitrate)

Official regulatory guidelines define specific conditions to maintain the stability and safety of Carmil tablets.

Storage Requirements

Condition Requirement
Temperature Store at controlled room temperature, typically between 15 C and 30 C (59 F and 86 F). Do not store above 25 C in some regions.
Environment Protect from excessive moisture and light.
Handling Keep the container tightly closed. Do not refrigerate or freeze the medication.
Safety Keep Carmil strictly out of the reach of children.

Disposal Instructions

To dispose of expired or unused Carmil, do not discard it in household trash or flush it down the toilet or sink. The medicine must be disposed of according to local pharmaceutical return schemes, such as returning it to a local pharmacy for proper collection.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Carmil found in:

A-Z Index: